Expert Interview
Discussing Vertex Pharmaceticals' results from the ongoing phase 1/2 study of VX-880 for the treatment of Type 1 Diabetes presented at the American Diabetes Association 84th Scientific Sessions
Ticker(s): VRTXInstitution: Novant Health
- Physician with 27+ years of practice Board Certified Endocrinology and Metabolism
- Treats 60+ Type 1 Diabetes pts per month
- Charlotte chapter Juvenile Diabetes Research Foundation board of directors
Do you want answers to these questions?
Slingshot Insights Explained
Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.
Reason
*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.
